SVSergei Vosko

Sergei Vosko

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sergei Vosko has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Pan-esophageal squamous papillomatosis with high grade dysplasia managed with endoscopic submucosal dissection

    by Yong Sul Kim, Sergei Vosko, Sunil Gupta, Brian Lam, Clarence Kerrison, Nicholas Graeme Burgess, Michael J. Bourke

    A 63-year-old woman presented to her local gastroenterologist with a two-year history of dysphagia. A barium swallow demonstrated free passage of liquid barium and a barium-soaked marshmallow but noted a small irregularity of the mucosal surface in the mid esophagus ([Fig. 1]). Subsequent gastroscopy revealed circumferential diffuse white-pink plaques with a cobblestone appearance, extending 23–38 cm from the incisors. Biopsies revealed squamous papillomatosis with multifocal low and high grade dysplasia. Computed tomography of the neck, chest, and abdomen was unremarkable. She was referred for consideration of endoscopic submucosal dissection (ESD). The lesion was assessed under high-definition white light and narrow-band imaging to determine the boundaries of the lesion ([Fig. 2]). This was marked with a 1.5-mm DualKnife J (Olympus, Tokyo, Japan). Following a submucosal lift (Gelofusine, indigo carmine, diluted adrenaline) and proximal mucosal incision, a ¾ circumferential submucosal tunnel was created. Once completed, the distal margin was incised to complete the tunnel. Clip-and-snare traction was utilized to facilitate further submucosal dissection, en bloc resection, and retrieval ([Video 1]). There were no adverse events. Final histological examination revealed extensive squamous intraepithelial neoplasia with mixed low and high grade dysplasia, and multifocal changes of squamous papillomatosis featuring hyperplastic squamous epithelium overlying finger-like cores of lamina propria. There was no evidence of recurrence at 72 months. As expected, a post-ESD stricture developed and was managed with serial dilations over six years ([Video 1]). Esophageal papillomatosis may be discovered incidentally as a solitary papular lesion. It is generally a benign growth and usually asymptomatic [1]. Diffuse esophageal involvement is exceptionally rare but can carry a risk of malignant transformation. Although the etiology is unclear, the human papillomavirus infection and chronic mucosal irritation have been proposed as potential causes [2] [3]. As demonstrated, ESD is a safe and effective treatment modality that facilitates organ-preserving eradication, which is sustained long-term. Endoscopy_UCTN_Code_TTT_1AO_2AC Article published online: 11 September 2025 © 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

  • Open Access

    Safety and efficacy of physician-administered balanced-sedation for the endoscopic mucosal resection of large non-pedunculated colorectal polyps

    by Sunil Gupta, Rajiv Kurup, Neal Shahidi, Sergei Vosko, Owen McKay, Simmi Zahid, Anthony Whitfield, Eric Y. Lee, Stephen John Williams, Nicholas Graeme Burgess, et al.

    Background and study aims Because of concerns about peri-procedural adverse events (AEs), guidelines recommend anesthetist-managed sedation (AMS) for long and complex endoscopic procedures. The safety and efficacy of physician-administered balanced sedation (PA-BS) for endoscopic mucosal resection (EMR) of large non-pedunculated colorectal polyps (LNPCPs) ≥20 mm is unknown. Patients and methods We compared PA-BS with AMS in a retrospective study of prospectively collected data from consecutive patients referred for management of LNPCPs (NCT01368289; NCT02000141). A per-patient propensity analysis was performed following a 1:2 nearest-neighbor (Greedy-type) match, based on age, gender, Charlson comorbidity index, and lesion size. The primary outcome was any peri-procedural AE, which included hypotension, hypertension, tachycardia, bradycardia, hypoxia, and new arrhythmia. Secondary outcomes were unplanned admissions, 28-day re-presentation, technical success, and recurrence. Results Between January 2016 and June 2020, 700 patients underwent EMR for LNPCPs, of whom 638 received PA-BS. Among them, the median age was 70 years (interquartile range [IQR] 62–76 years), size 35 mm (IQR 25–45 mm), and duration 35 minutes (IQR 25–60 minutes). Peri-procedural AEs occurred in 149 (23.4%), most commonly bradycardia (116; 18.2%). Only five (0.8%) required an unplanned sedation-related admission due to AEs (2 hypotension, 1 arrhythmia, 1 bradycardia, 1 hypoxia), with a median inpatient stay of 1 day (IQR 1–3 days). After propensity-score matching, there were no differences between PA-BS and AMS in peri-procedural AEs, unplanned admissions, 28-day re-presentation rates, technical success or recurrence. Conclusions Physician-administered balanced sedation for the EMR of LNPCPs is safe. Peri-procedural AEs are infrequent, transient, rarely require admission (<1%), and are experienced in similar frequencies to those receiving anesthetist-managed sedation.


  • Endoscopic resection-related colorectal strictures: risk factors, management, and long-term outcomes

    by Sunil Gupta, Sergei Vosko, Neal Shahidi, Timothy O’sUllivan, Oliver Cronin, Anthony Whitfield, Rajiv Kurup, Mayenaaz Sidhu, Eric Yong Tat Lee, Stephen J. Williams, et al.

    Introduction Colorectal strictures related to endoscopic resection (ER) of large nonpedunculated colorectal polyps (LNPCPs) may be problematic. Data on prevalence, risk factors, and management are limited. We report a prospective study of colorectal strictures following ER and describe our approach to management. Methods We analyzed prospectively collected data over 150 months, until June 2021, for patients who underwent ER for LNPCPs ≥ 40 mm. The ER defect size was graded as < 60 %, 60 %–89 %, or ≥ 90 % of the luminal circumference. Strictures were considered “severe” if patients experienced obstructive symptoms, “moderate” if an adult colonoscope could not pass the stenosis, or “mild” if there was resistance on successful passage. Primary outcomes included stricture prevalence, risk factors, and management. Results 916 LNPCPs ≥ 40 mm in 916 patients were included (median age 69 years, interquartile range 61–76 years, male sex 484 [52.8 %]). The primary resection modality was endoscopic mucosal resection in 859 (93.8 %). Risk of stricture formation with an ER defect ≥ 90 %, 60 %–89 %, and < 60 % was 74.2 % (23/31), 25.0 % (22/88), and 0.8 % (6 /797), respectively. Severe strictures only occurred with ER defects ≥ 90 % (22.6 %, 7/31). Defects < 60 % conferred low risk of only mild strictures (0.8 %, 6/797). Severe strictures required earlier (median 0.9 vs. 4.9 months; P = 0.01) and more frequent (median 3 vs. 2; P = 0.02) balloon dilations than moderate strictures. Conclusion Most patients with ER defects ≥ 90 % of luminal circumference developed strictures, many of which were severe and required early balloon dilation. There was minimal risk with ER defects < 60 %.


  • Simple optical evaluation criteria reliably identify the post-endoscopic mucosal resection scar for benign large non-pedunculated colorectal polyps without tattoo placement

    by Neal Shahidi, Sunil Gupta, Anthony Whitfield, Sergei Vosko, Owen McKay, Oliver Cronin, Simmi Zahid, Nicholas G. Burgess, Michael J. Bourke

    Background Recognition of the post-endoscopic mucosal resection (EMR) scar is critical for large (≥ 20 mm) non-pedunculated colorectal polyp (LNPCP) management. The utility of intraluminal tattooing to facilitate scar identification is unknown. Methods We evaluated the ability of simple easy-to-use optical evaluation criteria to detect the post-EMR scar, with or without tattoo placement, in a prospective observational cohort of LNPCPs referred for endoscopic resection. The primary outcome was scar identification, further stratified by lesion size (20–39 mm, ≥ 40 mm) and histopathology (adenomatous, serrated). Results 1023 LNPCPs underwent both successful EMR and first surveillance colonoscopy (median size 35 mm, IQR 30–50 mm); 124 (12.1 %) had an existing tattoo or a tattoo placed at the index EMR. The post-EMR scar was identified in 1020 patients (99.7 %). The presence of a tattoo did not affect scar identification (100.0 % vs. 99.7 %; P > 0.99). There was no difference for LNPCPs 20–39 mm, LNPCPs ≥ 40 mm, adenomatous LNPCPs, and serrated LNPCPs (all P > 0.99). Conclusions The post-EMR scar can be reliably identified with simple easy-to-use optical evaluation criteria, without the need for universal tattoo placement.


  • Open Access

    Achalasia During Pregnancy: Proposed Management Algorithm Based on a Thorough Literature Review

    by Sergei Vosko, Daniel L Cohen, Ortal Neeman, Shai Matalon, Efrat Broide, Haim Shirin

    Sergei Vosko, Daniel L Cohen,* Ortal Neeman, Shai Matalon, Efrat Broide, and Haim Shirin. J Neurogastroenterol Motil 2021;27:8-18. https://doi.org/10.5056/jnm20181